Page last updated: 2024-10-20

pyrazole and Carcinoma, Hepatocellular

pyrazole has been researched along with Carcinoma, Hepatocellular in 6 studies

1H-pyrazole : The 1H-tautomer of pyrazole.

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Dömötör, O1
Kiss, MA1
Gál, GT1
May, NV1
Spengler, G1
Nové, M1
Gašparović, AČ1
Frank, É1
Enyedy, ÉA1
Elshaier, YAMM1
Shaaban, MA1
Abd El Hamid, MK1
Abdelrahman, MH1
Abou-Salim, MA1
Elgazwi, SM1
Halaweish, F1
Harras, MF1
Sabour, R1
Hawash, MM1
Kahraman, DC1
Eren, F1
Cetin Atalay, R1
Baytas, SN1
Nieto, N1
Marí, M1
Cederbaum, AI2
Wu, D1

Other Studies

6 other studies available for pyrazole and Carcinoma, Hepatocellular

ArticleYear
Solution equilibrium, structural and cytotoxicity studies on Ru(η
    Journal of inorganic biochemistry, 2020, Volume: 202

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Proliferation; C

2020
Design and synthesis of pyrazolo[3,4-d]pyrimidines: Nitric oxide releasing compounds targeting hepatocellular carcinoma.
    Bioorganic & medicinal chemistry, 2017, 06-15, Volume: 25, Issue:12

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Drug Design; Hep G

2017
Design, synthesis and biological evaluation of novel 1,3,4-trisubstituted pyrazole derivatives as potential chemotherapeutic agents for hepatocellular carcinoma.
    Bioorganic chemistry, 2018, Volume: 78

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; CDC2 Protein Kinase; Cell Cy

2018
Synthesis and biological evaluation of novel pyrazolic chalcone derivatives as novel hepatocellular carcinoma therapeutics.
    European journal of medicinal chemistry, 2017, Mar-31, Volume: 129

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Cycle Prot

2017
Cytochrome P450 2E1 responsiveness in the promoter of glutamate-cysteine ligase catalytic subunit.
    Hepatology (Baltimore, Md.), 2003, Volume: 37, Issue:1

    Topics: 5' Flanking Region; Allyl Compounds; Animals; Antioxidants; Arachidonic Acid; Carcinoma, Hepatocellu

2003
Sodium salicylate increases CYP2E1 levels and enhances arachidonic acid toxicity in HepG2 cells and cultured rat hepatocytes.
    Molecular pharmacology, 2001, Volume: 59, Issue:4

    Topics: Allyl Compounds; Animals; Antioxidants; Apoptosis; Arachidonic Acid; Carcinoma, Hepatocellular; Cell

2001